March 31, 2026 · Form 4 insider transaction
Skaff Michael C bought 429,957 shares of Vivos Therapeutics, Inc. at $1.34 per share, a transaction worth $576.1K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 2 days after the transaction.
The Pre-Funded Warrant has a term ending on the complete exercise of the Pre-Funded Warrant.; Michael C. Skaff serves as Managing Director of SP Manager LLC, the Manager of V-Co Investors 3 LLC. Michael C. Skaff and SP Manager LLC disclaim beneficial ownership of these securities except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose.